Literature DB >> 16374428

Biphasic changes of epithelial sodium channel abundance and trafficking in common bile duct ligation-induced liver cirrhosis.

S W Kim1, W Wang, M C Sassen, K C Choi, J S Han, M A Knepper, T E N Jonassen, J Frøkiaer, S Nielsen.   

Abstract

We hypothesize that dysregulation of the epithelial sodium channel (ENaC) may be responsible for the increased sodium retention in liver cirrhosis. Liver cirrhosis was induced by common bile duct ligation (CBDL). We examined the abundance of ENaC subunits and type 2 isoform of 11beta-hydroxysteroid dehydrogenase (11betaHSD2) in the kidney by immunoblotting and immunohistochemistry at 6 or 8 weeks after operation. At 6 weeks, cirrhotic rats had developed ascites and displayed a positive sodium balance. The urinary sodium excretion and fractional excretion of sodium were decreased, while plasma aldosterone was unchanged. The abundance of ENaC subunits was not changed in the cortex and outer stripe of the outer medulla (OSOM). In contrast, immunoperoxidase microscopy revealed an increased apical targeting of alpha-, beta- and gammaENaC in late distal convoluted tubule, connecting tubule and collecting duct. Moreover, 11betaHSD2 abundance was decreased in the cortex/OSOM and inner stripe of the outer medulla. At 8 weeks, urinary sodium excretion and fractional excretion of sodium were not changed, while the plasma aldosterone level was decreased. The expression of ENaC subunits was decreased in the cortex/OSOM. Immunoperoxidase microscopy confirmed decreased expression of ENaC subunits, whereas subcellular localization was not changed. These results suggest that increased apical targeting of ENaC subunits and diminished abundance of 11betaHSD2 may contribute to promote sodium retention in the sodium-retaining stage of liver cirrhosis (at 6 weeks). The subsequent decreased expression and reduced targeting of ENaC subunits may play a role in promoting sodium excretion in the later stage of liver cirrhosis (at 8 weeks).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16374428     DOI: 10.1038/sj.ki.5000018

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Changes of atrial natriuretic Peptide system in rats with puromycin aminonucleoside-induced nephrotic syndrome.

Authors:  Eun Hui Bae; Jongun Lee; Seong Kwon Ma; Soo Wan Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-02-28       Impact factor: 2.016

2.  ENaC activity in collecting ducts modulates NCC in cirrhotic mice.

Authors:  David Mordasini; Dominique Loffing-Cueni; Johannes Loffing; Rohrbach Beatrice; Marc P Maillard; Edith Hummler; Michel Burnier; Geneviève Escher; Bruno Vogt
Journal:  Pflugers Arch       Date:  2015-06-10       Impact factor: 3.657

3.  Changes in endothelin receptor type B and neuronal nitric oxide synthase in puromycin aminonucleoside-induced nephrotic syndrome.

Authors:  Eun Hui Bae; Soo Wan Kim
Journal:  Korean J Physiol Pharmacol       Date:  2010-08-31       Impact factor: 2.016

Review 4.  ANP-induced signaling cascade and its implications in renal pathophysiology.

Authors:  Franziska Theilig; Qingyu Wu
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-28

5.  Changes of renal AQP2, ENaC, and NHE3 in experimentally induced heart failure: response to angiotensin II AT1 receptor blockade.

Authors:  Sophie C Lütken; Soo Wan Kim; Thomas Jonassen; David Marples; Mark A Knepper; Tae-Hwan Kwon; Jørgen Frøkiaer; Søren Nielsen
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

6.  Regulation of Renal Hemodynamics and Function by RGS2.

Authors:  Patrick Osei-Owusu; Elizabeth A Owens; Li Jie; Janaina S Reis; Steven J Forrester; Tatsuo Kawai; Satoru Eguchi; Harpreet Singh; Kendall J Blumer
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

Review 7.  Dysregulation of ENaC in Animal Models of Nephrotic Syndrome and Liver Cirrhosis.

Authors:  Soo Wan Kim
Journal:  Electrolyte Blood Press       Date:  2006-03

8.  Downregulation of Ca2+-Activated Cl- Channel TMEM16A Mediated by Angiotensin II in Cirrhotic Portal Hypertensive Mice.

Authors:  Rubii Kondo; Nami Furukawa; Akari Deguchi; Naoki Kawata; Yoshiaki Suzuki; Yuji Imaizumi; Hisao Yamamura
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.